Biochemical Markers and Skeletal Metastases
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health
- Vol. 415, S138-S147
- https://doi.org/10.1097/01.blo0000092979.12414.54
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Bone markers in the management of metastatic bone diseaseCancer Treatment Reviews, 2001
- Molecular mechanisms of osteolytic bone metastasesCancer, 2000
- Biochemical markers and skeletal metastasesCancer, 2000
- Biological Variability of Serum and Urinary N-Telopeptides of Type I Collagen in Postmenopausal WomenJournal of Bone and Mineral Research, 2000
- Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic MetastasesCritical Reviews™ in Eukaryotic Gene Expression, 2000
- Early Changes in Biochemical Markers of Bone Turnover Predict the Long-Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical TrialJournal of Bone and Mineral Research, 1998
- Mechanisms of bone metastasisCancer, 1997
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996
- Urinary Pyridinoline and Deoxypyridinoline as Potential Markers of Bone Metastasis in Patients with Prostate CancerJournal of Urology, 1996
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992